Teladoc (TDOC) Gets $7 Price Target: Can It Double?
Barclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...
Index Level plays a key role across markets, signaling potential strength or weakness. Use these insights to assess opportunities and guard against risk.
27,528 articlesBarclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...
A tidal wave of data centers is pushing power demands higher. Five dividend stocks are quietly funding the grid expan...
Dave Ramsey reveals a practical, three-bucket framework to turn generosity into a deliberate, scalable habit as donor...
An AI forecast from Claude points to multix gains for XRP, Solana, and Dogecoin by 2026. The predictions hinge on ado...
Geopolitical tensions push yields higher, nudging mortgage rates tick higher and complicating spring homebuying for m...
A Wall Street note imagines a SpaceX IPO delivering about 40% upside, powered by a diversified revenue mix. This repo...
Two hugely popular fixed-income ETFs sit at the heart of many portfolios: TLT and LQD. This guide breaks down their d...
Debt worries surround a proposed $1.5 trillion boost to the Pentagon budget, drawing pushback from fiscal hawks and r...
With yields in play and inflation cooling only slowly, a disciplined dividend portfolio that outlasts a 4% rule offer...
In the month since THYP debuted on Nasdaq, hype etfs quietly pulled $161 million in net inflows across the three US-t...
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
A common target for retirement savings is around $1.26 million. This article breaks down what that number means in re...